-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731.O2.6 731. Clinical Autologous Transplantation: Results II

Clinical Autologous Transplantation: Results Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 7:00 AM-8:30 AM
W224CDGH, Level 2 (Orange County Convention Center)
Moderators:
Ginna Laport, MD, Stanford University and Leona Holmberg, Fred Hutchinson Cancer Rsch. Ctr.

Disclosures:
No relevant conflicts of interest to declare.
7:00 AM

Eric Van Den Neste, MD, PhD1*, Norbert Schmitz, MD2, Nicolas Mounier, MD, PhD3*, Devinder Gill, MB FRCPath FRACP FRCPA4, Marek Trneny, M.D., Ph.D., Prof.5, Noel Milpied6, John A. Radford, MD7*, Nicolas Ketterer8, Ofer Shpilberg, MD9*, Ulrich Dührsen10*, David Ma, MD11*, Josette Briere12*, Catherine Thieblemont12, Gilles A. Salles, MD, PhD13, Craig Moskowitz, MD14, Bertran Glass15* and Christian Gisselbrecht16

1Hematology Department, Cliniques universitaires UCL Saint-Luc, Brussels, Belgium
2Abt. Hämatologie und Stammzelltransplantation, ASKLEPIOS Klinik St. Georg, Hamburg, Germany
3Hematology Department, CHU De Nice, Hopital De L'Archet, Nice, France
4Dept. of Haematology,Pathology Qld, Princess Alexandra Hospital, Brisbane, Australia
5First Dep. of Medicine, Charles University General Hospital, Prague, Czech Republic
6Service d’Hematologie Clinique et Therapie Cellulaire, CHU Haut-Lévêque, Bordeaux, France
7Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
8Department of Oncology, Lausanne Hospital, Lausanne, Switzerland
9Assuta Medical Center, Tel Aviv, Israel
10Klinik für Hämatologie Universitätsklinikum, Essen, Germany
11Blood Stem Cells and Cancer Research Unit, St Vincent's Hospital Centre for Applied Medical Research, Darlinghurst, Australia
12Hôpital Saint-Louis, Paris, France
13Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
1415Memorial Sloan Kettering Cancer Center, New York
152AsklepiosKlinik St. Georg, AbteilungHämatologie und Stammzelltransplantation, Hambourg, Germany
16Dept. of Hematology, Hôpital Saint Louis, Paris, France

7:15 AM

Robert Chen1, Hongli Li, PhD2*, Steven H. Bernstein, MD3, Lisa M. Rimsza, M.D.4, Stephen J. Forman, MD5, Louis Constine, M.D.6, Thomas C. Shea, MD7, Amanda F. Cashen, MD8, Kristie A. Blum, MD9, Timothy S. Fenske, MD10, Paul M. Barr, MD11, Michael Leblanc, PhD2*, Richard I. Fisher, MD12*, Bruce D. Cheson, MD13, Sonali M. Smith, MD14, Malek Faham15*, Jennifer Wilkins15*, John P. Leonard, MD16, Brad S. Kahl, MD17 and Jonathan W. Friedberg, MD, MMSc18

1City of Hope, Duarte, CA
2SWOG Statistical Center, Seattle, WA
3James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY
4University of Arizona, Tucson, AZ
5Department of Hematology and HCT, City of Hope, Duarte, CA
6University of Rochester, James P. Wilmot Cancer Center, Rochester, NY
7Division of Hematology/Oncology, UNC School of Medicine, Chapel Hill, NC
8Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
9Division of Hematology, The Ohio State University, Columbus, OH
10Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
11Wilmot Cancer Institute, University of Rochester, Rochester, NY
12Fox Chase Cancer Center/Temple University School of Medicine, Philadelphia, PA
13Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
14University of Chicago, Chicago, IL
15Adaptive Biotech, san francisco, CA
16Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY
17University of Wisconsin, Madison
18University of Rochester, Rochester, NY

7:30 AM

Robert Chen1, Joycelynne Palmer, PhD2*, Peter Martin, MD3, Saro Armenian, DO, MPH1, Nichun Tsai4*, Michelle Mott5*, Firoozeh Sahebi6, Ji-Lian Cai, MD, PhD7, Tanya Siddiqi, MD1, Leslie L. Popplewell, MD8, John P. Leonard, MD3, Auayporn P. Nademanee, MD9, Steven T. Rosen, MD10, Larry W. Kwak, MD11* and Stephen J. Forman, MD12

1City of Hope National Medical Center, Duarte, CA
2Department of Information Sciences, City of Hope, Duarte, CA
3Weill Cornell Medical College, New York, NY
4biostatistics, city of hope, duarte, CA
5hem/hct, city of hope, duarte, CA
6Judy and Bernard Briskin Myeloma Center, City of Hope Medical Center/So California Permanente Medical Group, Los Angeles, CA
7So California Permanente Kaiser Medical Grpty of Hope Nat'l Med. Ctr., San Marino, CA
8City of Hope, Duarte, CA
9Department of Hematology and HCT, City of Hope, Duarte, CA
10Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
11Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA
12Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

7:45 AM

Gunjan L Shah, MD MS1, Kurt S Bantilan, MPH2*, Stephanie L Verwys, BS3*, Susan J McCall, MSN ANP-BC4*, Joachim Yahalom, MD4*, Matthew J. Matasar, MD, MS5, Alison J Moskowitz, MD2 and Craig H. Moskowitz, MD2

1Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan-Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY

8:00 AM

Ana Jiménez Ubieto1*, Carlos Grande García2*, Lucrecia Yañez3*, Dolores Caballero, MD4*, Silvana Novelli, MD5*, María Jesús Rodriguez6*, Marina Manzanares7*, Reyes Arranz, MD8*, José Javier Ferreiro9*, Sabela Bobillo10*, Santiago Mercadal, MD11*, Andrea Galego12*, Javier López Jiménez13*, Carlos Vallejo14*, Carmen Albo15*, Elena Pérez16*, Carmen Marrero17*, Laura Magnano18*, Luis Palomera, MD PhD19*, Isidro Jarque20*, Erika Coria21*, Teresa Palomo22*, Pilar Martinez Sánchez2*, Armando López-Guillermo18, Antonio Salar, MD, PhD23* and Juan José Lahuerta2*

1Hematologia, Hospital 12 de Octubre, Madrid, Spain
2Hospital 12 de Octubre, Madrid, Spain
3Hematology Department, University Hospital Marques de Valdecilla, Santander, Spain
4Hospital Universitario de Salamanca, Salamanca, Spain
5Hospital Universitario Sant Pau, Barcelona, Spain
6Hospital Universitarion de Canarias, Tenerife, Spain
7Hospital Universitario de Jerez, Jerez, Spain
8Hospital Universitario La Princesa, Madrid, Spain
9Hospital Universitario Donostia-Aránzazu, San Sebastian, Spain
10Hospital Universitario Vall dHebron, Barcelona, Spain
11ICO L´Hospitalet, Hospitalet de Llobregat, Spain
12Hospital Universitario Juan Canalejo, A coruña, Spain
13Hospital Ramón y Cajal, Madrid, Spain
14Hospital central de Asturias, Oviedo, Spain
15Department of Hematology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
16Hospital General Universitario Morales Meseguer, Murcia, Spain
17Hospital Nuestra Señora La Candelaria, Santa Cruz de Tenerife, Spain
18Hospital Clinic,IDIPAS, Barcelona, Spain
19Department of Hematology, Hospital Universitario Lozano Blesa, Zaragoza, Spain
20Department of Hematology, Hospital Universitario La Fe, Valencia, Spain
21Hospital Clínico San Carlos, Madrid, Spain
22Hospital Universitario de Getafe, Getafe, Spain
23Hospital del Mar, Barcelona, Spain

8:15 AM

Alex F. Herrera, MD1, Matthew G. Mei, MD1, Lawrence Low, MD, PhD2, Reid W. Merryman, MD3*, Joo Y. Song, MD4, Tanya Paris5*, Tracey Stiller5*, Victoria Bedell5*, Heather Sun6*, Jennifer R. Brown, MD, PhD7, Lihua Elizabeth Budde, MD, PhD8, Robert Chen2, Matthew S. Davids, MD9, Arnold S. Freedman, MD10, David C. Fisher, MD10, Eric D. Jacobsen, MD10, Caron A. Jacobson, MD9, Haesook T. Kim, PhD11*, Ann S. LaCasce, MD9, Joyce Murata-Collins, PhD12, Auayporn P. Nademanee, MD13, Joycelynne Palmer, PHD14*, German A. Pihan, MD15, Tanya Siddiqi, MD8, Aliyah R Sohani, MD16, Leslie L. Popplewell, MD5, Jasmine Zain, MD17*, Larry W. Kwak, MD18*, David M. Weinstock10, Stephen J. Forman, MD19, Dennis D. Weisenburger, MD4, Young Kim, MD4, Scott J. Rodig, M.D., Ph.D.20, Amrita Krishnan5 and Philippe Armand, MD, PhD9

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA
2City of Hope National Medical Center, Duarte, CA
3Department of Medicine, Brigham and Women's Hospital, Boston, MA
4Department of Pathology, City of Hope National Medical Center, Duarte, CA
5City of Hope, Duarte, CA
6Department of Pathology, Brigham and Women's Hospital, Boston, MA
7Medical Oncology, Dana Farber Cancer Institute, Boston, MA
8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9Dana-Farber Cancer Institute, Boston, MA
10Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
11Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, MA
12City of Hope, Department of Pathology, Duarte, CA
13Department of Hematology and HCT, City of Hope, Duarte, CA
14Judy and Bernard Briskin Myeloma Center, City of Hope, Duarte, CA
15Pathology, BIDMC, Boston, MA
16Department of Pathology, Massachusetts General Hospital, Boston, MA
17Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
18Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA
19Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
20Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA

*signifies non-member of ASH